# Assessing the Impact of Elelyso on Bone Involvement Currently Treated With Other ERTs

> **NCT04353466** · NA · COMPLETED · sponsor: **Shaare Zedek Medical Center** · enrollment: 30 (actual)

## Conditions studied

- Gaucher Disease, Type 1

## Interventions

- **PROCEDURE:** quantitative chemical shift imaging (QCSI)
- **DRUG:** Elelyso

## Key facts

- **NCT ID:** NCT04353466
- **Lead sponsor:** Shaare Zedek Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-01
- **Primary completion:** 2021-07-31
- **Final completion:** 2021-07-31
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-10-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04353466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04353466, "Assessing the Impact of Elelyso on Bone Involvement Currently Treated With Other ERTs". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04353466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*